Tackling an Evolving Pandemic

The novel coronavirus, first detected in late 2019, continues to cause widespread illness and death, economic devastation, and long-term uncertainty throughout the world. As we look toward 2021, what can we expect?

In this video conversation, Jennifer Bouey discusses RAND’s rapid COVID-19 response, including insights and analysis to help strengthen and safeguard communities, rethink and retool institutions, and determine the best ways forward. She talks about what we’ve learned, and what the coming months might bring as the crisis continues to unfold and evolve. Brandon Baker hosts.

Learn More

COVID-19 Pandemic: Insights from RAND
RAND research and expertise can inform immediate policy responses to address the disastrous effects of COVID-19—and help aid in recovery long after the disease stops spreading.
Apr 10, 2020
Who Would Benefit from a Successful Chinese COVID-19 Vaccine?
China, one of the world's largest producers of vaccines, could be among the first to produce one for COVID-19. If that happens, then would China be able to produce sufficient doses for domestic use? And which other countries would likely benefit?
Aug 12, 2020
Jennifer Bouey @BoueyHuang
COVID-19 Screening in the Workplace
Workplaces are checking for COVID-19 symptoms verbally, with a paper form or app, with onsite temperature checks, or by combining these approaches. Which methods are likely to detect infection and help employees feel safer? And which are safe, feasible, and least problematic in terms of privacy?
Sep 17, 2020
Courtney A. Gidengil @c_gidengil, Shira H. Fischer @ShiraFischer, et al.
新冠肺炎背景下的中国卫生体制改革和全球卫生战略
在 2020 年 5 月 7 日举行的美中经济与安全评估委员会上出示的证词。
May 7, 2020